High Expression of FAP in Colorectal Cancer Is Associated With Angiogenesis and Immunoregulation Processes

Fibroblast activation protein α (FAP) plays an important role in tissue remodeling and helps tumor cells invade surrounding tissue. We sought to investigate FAP as a prognostic molecular marker in colorectal cancer (CRC) using immunohistochemical and transcriptomic data. FAP expression and clinicopathological information were obtained from The Cancer Genome Atlas data set. The association of FAP expression and tissue cellular heterogeneity landscape was explored using the xCell method. We evaluated FAP protein expression in a cohort of 92 CRCs and 19 non-tumoral tissues. We observed that FAP was upregulated in tumors both at the mRNA and protein levels, and its expression was associated with advanced stages, poor survival, and consensus molecular subtype 4. FAP expression was also associated with angiogenesis and collagen degradation. We observed an enrichment in immune-cell process–related genes associated with FAP overexpression. Colorectal cancers with high FAP expression display an inflamed phenotype enriched for macrophages and monocytes. Those tumors showed enrichment for regulatory T cell populations and depletion of TH1 and natural killer T cells, pointing to an immunosuppressive environment. Colorectal cancers with high levels of stromal FAP are associated with aggressive disease progression and survival. Our results suggest that FAP plays additional roles in tumor progression such as modulation of angiogenesis and immunoregulation in the tumor microenvironment.

• Publication year

  2020

• Venue

  Frontiers in Oncology

• Publication date

  2020-07-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3389/fonc.2020.00979PMID 32733792PMCID 7362758
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fibroblast Activation Protein (FAP) Overexpression Induces Epithelial–Mesenchymal Transition (EMT) in Oral Squamous Cell Carcinoma by Down-Regulating Dipeptidyl Peptidase 9 (DPP9)

  2020cited by this paper
• Fibroblast activation protein-positive fibroblasts promote tumor progression through secretion of CCL2 and interleukin-6 in esophageal squamous cell carcinoma

  2019cited by this paper
• 68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer

  2019cited by this paper
• Comparisons of cancer-associated fibroblasts in the intratumoral stroma and invasive front in colorectal cancer

  2019influential reference
• Increased expression of cancer-associated fibroblast markers at the invasive front and its association with tumor-stroma ratio in colorectal cancer

  2019cited by this paper
• The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study

  2018cited by this paper
• Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer.

  2018cited by this paper
• clusterProfiler: An universal enrichment tool for functional and comparative study

  2018cited by this paper
• 68Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers

  2018cited by this paper
• CMScaller: an R package for consensus molecular subtyping of colorectal cancer pre-clinical models

  2017cited by this paper
• A pathology atlas of the human cancer transcriptome

  2017influential reference
• Cyclophosphamide enhances anti-tumor effects of a fibroblast activation protein α-based DNA vaccine in tumor-bearing mice with murine breast carcinoma

  2017cited by this paper
• xCell: digitally portraying the tissue cellular heterogeneity landscape

  2017cited by this paper
• Mesenchymal Cells in Colon Cancer.

  2017cited by this paper
• Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016

  2017cited by this paper
• Fibroblast Activation Protein-α-Positive Fibroblasts Promote Gastric Cancer Progression and Resistance to Immune Checkpoint Blockade

  2017cited by this paper
• FAP positive fibroblasts induce immune checkpoint blockade resistance in colorectal cancer via promoting immunosuppression.

  2017cited by this paper
• Fibroblast activation protein‐α, a stromal cell surface protease, shapes key features of cancer associated fibroblasts through proteome and degradome alterations

  2016cited by this paper
• Fast gene set enrichment analysis

  2016cited by this paper
• FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3-CCL2 Signaling.

  2016cited by this paper
• An algorithm for fast preranked gene set enrichment analysis using cumulative statistic calculation

  2016cited by this paper
• Fibroblast activation in cancer: when seed fertilizes soil

  2016cited by this paper
• Tumor budding in colorectal cancer--ready for diagnostic practice?

  2016cited by this paper
• PD-1 blockade in tumors with mismatch-repair deficiency

  2015cited by this paper
• TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data

  2015cited by this paper
• PD-1 blockade in tumors with mismatch repair deficiency.

  2015cited by this paper
• Immune checkpoints and immunotherapy for colorectal cancer

  2015cited by this paper
• CCL2 Promotes Colorectal Carcinogenesis by Enhancing Polymorphonuclear Myeloid-Derived Suppressor Cell Population and Function

  2015cited by this paper
• The Consensus Molecular Subtypes of Colorectal Cancer

  2015cited by this paper
• PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.

  2015cited by this paper
• The Carcinoma-Associated Fibroblast Expressing Fibroblast Activation Protein and Escape from Immune Surveillance

  2014cited by this paper
• 3'-UTR poly(T/U) tract deletions and altered expression of EWSR1 are a hallmark of mismatch repair-deficient cancers.

  2014cited by this paper
• The relationship between tumour stroma percentage, the tumour microenvironment and survival in patients with primary operable colorectal cancer.

  2014cited by this paper
• Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours

  2013cited by this paper
• High intratumoral expression of fibroblast activation protein (FAP) in colon cancer is associated with poorer patient prognosis

  2013cited by this paper
• Prognostic impact of lymphatic invasion of colorectal cancer: a single-center analysis of 1,616 patients over 24 years.

  2013cited by this paper
• Importance of chemokine (CC-motif) ligand 2 in breast cancer

  2012cited by this paper
• Comprehensive molecular characterization of human colon and rectal cancer

  2012cited by this paper
• Fibroblast activation protein in remodeling tissues.

  2012cited by this paper
• Cancer-associated fibroblasts correlate with poor prognosis in rectal cancer after chemoradiotherapy.

  2011influential reference
• FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells

  2011cited by this paper
• Colorectal cancer cells activate adjacent fibroblasts resulting in FGF1/FGFR3 signaling and increased invasion.

  2011cited by this paper
• A scaling normalization method for differential expression analysis of RNA-seq data

  2010cited by this paper
• Phase II trial of talabostat and docetaxel in advanced non-small cell lung cancer.

  2009cited by this paper
• edgeR: a Bioconductor package for differential expression analysis of digital gene expression data

  2009cited by this paper
• Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma

  2009cited by this paper
• Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice.

  2009cited by this paper
• Effective Immunoconjugate Therapy in Cancer Models Targeting a Serine Protease of Tumor Fibroblasts

  2008cited by this paper
• The Carcinoma–Stromal Ratio of Colon Carcinoma Is an Independent Factor for Survival Compared to Lymph Node Status and Tumor Stage

  2007cited by this paper
• Effect of fibroblast activation protein and alpha2-antiplasmin cleaving enzyme on collagen types I, III, and IV.

  2007cited by this paper
• Phase II trial of single agent Val-boroPro (talabostat) inhibiting fibroblast activation protein in patients with metastatic colorectal cancer

  2007cited by this paper
• Clinical Implications of Fibroblast Activation Protein in Patients with Colon Cancer

  2007influential reference
• Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake.

  2006cited by this paper
• Fibroblast activation protein-alpha and dipeptidyl peptidase IV (CD26): cell-surface proteases that activate cell signaling and are potential targets for cancer therapy.

  2005cited by this paper
• Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts.

  2005cited by this paper
• From the Cover: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

  2005cited by this paper
• Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature

  2005cited by this paper
• Seprase promotes rapid tumor growth and increased microvessel density in a mouse model of human breast cancer.

  2004cited by this paper
• Increased expression of caveolin‐1 and microvessel density correlates with metastasis and poor prognosis in clear cell renal cell carcinoma

  2004cited by this paper
• Chemokines in the pathogenesis of vascular disease.

  2004cited by this paper
• On the exact distribution of maximally selected rank statistics

  2003cited by this paper
• Promotion of tumor growth by murine fibroblast activation protein, a serine protease, in an animal model.

  2002cited by this paper
• Expression of the fibroblast activation protein during mouse embryo development.

  2001cited by this paper
• Fibroblast Activation Protein, a Dual Specificity Serine Protease Expressed in Reactive Human Tumor Stromal Fibroblasts*

  1999cited by this paper
• Vascular endothelial growth factor (VEGF) expression and survival in human epithelial ovarian carcinomas.

  1997cited by this paper
• Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers.

  1990cited by this paper

• Unveiling the tumor microenvironment in colorectal cancer therapeutic resistance

  2026cites this paper
• Thrombosis-related gene signature predicts prostate cancer recurrence and immune therapy: insights from retrospective cohorts, bioinformatics, and experimental validation

  2026cites this paper
• Phenotypic and ultrastructural heterogeneity of fibroblasts and vasculogenic mimicry in rectal adenocarcinoma following neoadjuvant chemoradiotherapy

  2025cites this paper
• Identification of Subtype-Specific Vulnerabilities in Resistant Glioblastoma: A Computational Pipeline for Biomarkers and Drug Discovery.

  2025cites this paper
• Quantifying Spatiotemporal Heterogeneity of Tumor Metabolism and Vasculature with a Multiparametric Point-of-Investigation Microscope

  2025cites this paper
• Structure-Property Investigation of New "KetoFAPI" Inhibitors of Fibroblast Activation Protein (FAP): Discovery of Highly Potent, Selective Compounds with Prolonged Residence Times and Promising Radiotheranostic Potential.

  2025cites this paper
• Prognostic implications of cancer-associated fibroblasts and desmoplastic reaction in stage III colon cancer risk groups.

  2025cites this paper
• Predicting fibroblast activation protein overexpression in the overall survival rate of cancer patients: a systematic review and meta-analysis

  2025cites this paper
• Synthesis and Preclinical Evaluation of Druglike 18F-Labeled Fibroblast Activation Protein (FAP) Inhibitors with Enhanced Tumor Retention.

  2025cites this paper
• Fibroblast activation protein-expression in colorectal carcinomas and implications for clinical application.

  2025cites this paper
• Tumour- and Non-Tumour-Associated Factors That Modulate Response to PD-1/PD-L1 Inhibitors in Non-Small Cell Lung Cancer

  2025cites this paper
• Validation of fibroblast activation protein and α‐smooth muscle actin as prognostic biomarkers in prostate cancer through AI‐assisted image analysis of dual‐marker IHC

  2025cites this paper
• Cancer-associated fibroblasts and their prognostic role in colorectal cancer: review and meta-analysis

  2025cites this paper
• “FAPI-PET: a new chapter in oncologic molecular imaging”

  2025cites this paper
• Understanding the Cancer-Associated Fibroblast (CAF) and Its Biomarker Fibroblast Activation Protein (FAP), and Aspects in Human Liver Cancer.

  2025cites this paper
• Synthesis and radiolabelling strategies of fibroblast activation protein ligands: a review.

  2025cites this paper
• Design, Synthesis, and Evaluation of OncoFAP Derivatives with the Albumin Binder as Novel Antitumor Radiopharmaceuticals

  2025cites this paper
• Interactions between cancer-associated fibroblasts and T-cells: functional crosstalk with targeting and biomarker potential

  2024cites this paper
• The Value of Machine Learning-based Radiomics Model Characterized by PET Imaging with 68Ga-FAPI in Assessing Microvascular Invasion of Hepatocellular Carcinoma.

  2024cites this paper
• Fibroblast Activation Protein-α Expression in Cancer-Associated Fibroblasts Shows the Poor Survival of Colorectal Cancer via Immune-Mediated Pathways

  2024cites this paper
• Transcriptomic, mutational and structural bioinformatics approaches to explore the therapeutic role of FAP in predominant cancer types

  2024cites this paper
• Clinical applications of fibroblast activation protein inhibitor positron emission tomography (FAPI-PET)

  2024cites this paper
• Podoplanin Expression in Early-Stage Colorectal Cancer-Associated Fibroblasts and Its Utility as a Diagnostic Marker for Colorectal Lesions

  2024cites this paper
• Cancer-Associated Fibroblast Proteins as Potential Targets against Colorectal Cancers

  2024cites this paper
• Hepatocellular Carcinoma Immune Microenvironment Analysis: A Comprehensive Assessment with Computational and Classical Pathology.

  2024cites this paper
• Cancer-associated fibroblast cell surface markers as potential biomarkers or therapeutic targets in lung cancer

  2024cites this paper
• Investigating the effect of Fusobacterium nucleatum on the aggressive behavior of cancer-associated fibroblasts in colorectal cancer

  2024cites this paper
• Single‐cell transcriptome analysis reveals tumoral microenvironment heterogenicity and hypervascularization in human carotid body tumor

  2024cites this paper
• Expression of the plasma membrane citrate carrier (pmCiC) in human cancerous tissues—correlation with tumour aggressiveness

  2024cites this paper
• Exploring the efficacy of FAPI PET/CT in the diagnosis and treatment management of colorectal cancer: a comprehensive literature review and initial experience

  2024cites this paper
• The Impact of Cancer-Associated Fibroblasts on the Biology and Progression of Colorectal Carcinomas

  2024cites this paper
• Influencing factors and solution strategies of chimeric antigen receptor T-cell therapy (CAR–T) cell immunotherapy

  2024cites this paper
• Association of future cancer metastases with fibroblast activation protein-α: a systematic review and meta-analysis

  2024cites this paper
• Identifying immune cell infiltration and diagnostic biomarkers in heart failure and osteoarthritis by bioinformatics analysis

  2023cites this paper
• Predicting Microenvironment in CXCR4- and FAP-Positive Solid Tumors—A Pan-Cancer Machine Learning Workflow for Theranostic Target Structures

  2023cites this paper
• Synthesis and Preclinical Evaluation of Three Novel 68Ga-Labeled Bispecific PSMA/FAP-Targeting Tracers for Prostate Cancer Imaging

  2023cites this paper
• Intertumoral Differences Dictate the Outcome of TGF-β Blockade on the Efficacy of Viro-Immunotherapy

  2023cites this paper
• The added value of [^68Ga]Ga-DOTA-FAPI-04 PET/CT in pancreatic cancer: a comparison to [^18F]F-FDG

  2023cites this paper
• SPECT Imaging with Tc-99m-Labeled HYNIC-FAPI-04 to Extend the Differential Time Window in Evaluating Tumor Fibrosis

  2023cites this paper
• Role and mechanism of fibroblast-activated protein-α expression on the surface of fibroblast-like synoviocytes in rheumatoid arthritis

  2023cites this paper
• Novel 68Ga-Labeled Pyridine-Based Fibroblast Activation Protein-Targeted Tracers with High Tumor-to-Background Contrast

  2023cites this paper
• Joint analysis identified FAP as a prognostic and diagnostic biomarker correlated immune infiltration in gastric cancer.

  2023cites this paper
• Head-to-head comparison of different classes of FAP radioligands designed to increase tumor residence time: monomer, dimer, albumin binders, and small molecules vs peptides

  2023cites this paper
• Translational assessment of a DATA-functionalized FAP inhibitor with facile 68Ga-labeling at room temperature

  2023cites this paper
• The Prognostic and therapeutic value and clinical implications of fibroblast activation protein-α as a novel biomarker in colorectal cancer

  2023cites this paper
• FAPI PET/CT Imaging—An Updated Review

  2023cites this paper
• Fibroblast activation protein-α expression in fibroblasts is common in the tumor microenvironment of colorectal cancer and may serve as a therapeutic target

  2023influential citation
• 68Ga-FAPI-04 PET distinguishes malignancy from 18F-FDG-avid colorectal lesions.

  2023cites this paper
• Fibroblast Activation Protein Alpha (FAPα) in Fibrosis: Beyond a Perspective Marker for Activated Stromal Cells?

  2023cites this paper
• Immunotheranostic target modules for imaging and navigation of UniCAR T-cells to strike FAP-expressing cells and the tumor microenvironment

  2023cites this paper
• Single‐cell RNA sequencing to explore cancer‐associated fibroblasts heterogeneity: “Single” vision for “heterogeneous” environment

  2023cites this paper
• 68 Ga-FAPI-04 PET Distinguishes Malignancy from In�ammatory Lesions

  2022cites this paper
• [^177Lu]Lu-FAP-2286 therapy in a case of right lung squamous cell carcinoma with systemic metastases

  2022cites this paper
• Multiplexed immunofluorescence analysis of CAF-markers, EZH2 and FOXM1 in gastric tissue: associations with clinicopathological parameters and clinical outcomes

  2022cites this paper
• Evaluation of Blood Soluble CD26 as a Complementary Biomarker for Colorectal Cancer Screening Programs

  2022cites this paper
• Identification of Spatial Proteomic Signatures of Colon Tumor Metastasis: A Digital Spatial Profiling Approach

  2022cites this paper
• The role of the tumor microenvironment in colorectal cancer and the potential therapeutic approaches

  2022cites this paper
• Radionuclide imaging and therapy directed towards the tumor microenvironment: a multi-cancer approach for personalized medicine

  2022cites this paper
• Cancer Associated Fibroblasts - An Impediment to Effective Anti-Cancer T Cell Immunity

  2022cites this paper
• Collagen Family and Other Matrix Remodeling Proteins Identified by Bioinformatics Analysis as Hub Genes Involved in Gastric Cancer Progression and Prognosis

  2022cites this paper
• Fibroblast activation protein identifies Consensus Molecular Subtype 4 in colorectal cancer and allows its detection by 68Ga-FAPI-PET imaging

  2022cites this paper
• Advances in CAR-T Cell Genetic Engineering Strategies to Overcome Hurdles in Solid Tumors Treatment

  2022cites this paper
• Small peptide inhibitor from the sequence of RUNX3 disrupts PAK1–RUNX3 interaction and abrogates its phosphorylation-dependent oncogenic function

  2021cites this paper
• Microenvironmental markers are correlated with lymph node metastasis in invasive submucosal colorectal cancer

  2021cites this paper
• [68Ga]Ga-DOTA-FAPI-04 and [18F]FDG PET/CT in the Assessment of Pancreatic Tumors: A Comparison Study

  2021cites this paper
• Transcriptional Enhancer Factor Domain Family member 4 Exerts an Oncogenic Role in Hepatocellular Carcinoma by Hippo‐Independent Regulation of Heat Shock Protein 70 Family Members

  2021cites this paper
• Title: Microenvironmental markers are correlated with lymph node metastasis in invasive submucosal colorectal cancer Running title: Alterations in submucosal CRC

  2021cites this paper
• Development and Validation of a Novel Prognosis Prediction Model for Patients With Stomach Adenocarcinoma

  2021cites this paper
• Epigenetic priming in chronic liver disease impacts the transcriptional and genetic landscapes of hepatocellular carcinoma

  2021cites this paper
• Cancer-associated fibroblasts in colorectal cancer

  2021influential citation
• High expressions of CD10, FAP and GPR77 in CAFs are associated with chemoresistance and worse prognosis in gastric cancer

  2021cites this paper
• New Frontiers in Cancer Imaging and Therapy Based on Radiolabeled Fibroblast Activation Protein Inhibitors: A Rational Review and Current Progress

  2021cites this paper
• YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis

  2021cites this paper
• Regulation of Fibroblast Activation Protein-α Expression: Focus on Intracellular Protein Interactions.

  2021cites this paper
• Fibroblast activation protein inhibitor (FAPi) positive tumour fraction on PET/CT correlates with Ki-67 in liver metastases of neuroendocrine tumours

  2021cites this paper
• FAPI PET/CT: Will It End the Hegemony of 18F-FDG in Oncology?

  2020cites this paper
• A novel prognostic risk score model based on immune-related genes in patients with stage IV colorectal cancer

  2020cites this paper
• Radiotracer zur Diagnose des Prostatakarzinoms: Etablierte und neue Verfahren

  2020cites this paper
• the Assessment of Pancreatic Tumors: A Comparison Study

  year unknowncites this paper